Seen in the ED: Elevated Troponin
The patient is a young man who presents after resolution of several hours of chest pain. He is recovering from a lower GI illness and still taking Cipro. What's your Dx?
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 11, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
What’s Next in Brain Health? Lifestyle Interventions, Says One Expert
Henry Mahncke, PhD, explains why lifestyle interventions, such as diet and exercise, could be prescribed down the line to improve brain health.
Tailored Diabetes Risk Assessment May Reduce Racial/Ethnic Disparities in Diagnosis
Lowering thresholds for BMI value and age of first diabetes screening among large US minority populations could greatly increase rates of diagnosis and improve care.
Interview: Delay in Second-line T2D Treatment Among Younger US Veterans Sparks Investigator Concern
HbA1c levels over time were found higher at initiation of second-line treatment in veterans aged 55 years and younger, a trend unsettling to a new study's lead author.
Prototype of “Multi-tasking” Wearable Found to Continuously Monitor Glucose, Alcohol, and Lactate Levels
The wearable device allows users to monitor their health while also performing their regular daily activities.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 10, 2022
Study: Only 3% of Adults with Overweight or Obesity in England are Referred to Weight Management Programs by Primary Care Clinician
Women, Black individuals, and adults diagnosed with overweight or obesity in more recent years were more likely to receive a referral, according to new study.
Obesity Rose Disproportionately Among Low-income Youth During Early COVID-19
The proportion of overweight, obesity, or severe obesity increased from 38% to 45% among 4500 young people seen in a primary care network where most receive public insurance.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 9, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 6, 2022
Investigational Apple Watch App Effectively Identified Left Ventricular Dysfunction using AI
New study presented at Heart Rhythm 2022 showed applying AI to an Apple Watch ECG can effectively identify LV dysfunction in a nonclinical setting.
FDA Restricts Use of J&J COVID-19 Vaccine after New Evaluation of TTS Risk
Administration of the J&J vaccine is now limited to those aged ≥18 years who cannot access other COVID-19 vaccines or are unable to receive them.
Study Author Reviews Results: Trends in Time to Initiation of Second-line T2D Treatment
Initiation of second-line type 2 diabetes treatment is lagging while A1c at the time it is introduced is climbing. The author of a new study highlights his findings on clinical inertia.
New Findings Suggest Need for Sex-specific Strategies to Prevent Heart Attacks in Young Adults
Seven risk factors accounted for 85% of the risk of first acute myocardial infarction in young adults in a new study.
Dapagliflozin Now Poised to Treat HF Across Full Spectrum of Disease: DELIVER Phase 3 Top Line Findings
High-level results show the trial met its composite primary endpoint, lowering risk of CV death or worsening disease in patients with HFmrEF/HFpEF.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 4, 2022
When Does Cannabis Use Become Addictive? Expert Explains How to Help Patients Navigate This Grey Area
As more states legalize cannabis for recreational purposes, it is critical for clinicians to help patients safely navigate its use.
Black Patients with AF Often Don't Receive Anticoagulant at Hospital Discharge, Study Suggests
Black patients hospitalized with atrial fibrillation were 25% less likely to receive oral anticoagulants upon discharge according to a large national registry study.
SGLT-2 Inhibitor and GLP-1 Receptor Agonist Prescribing Trends 2015-2020
PCPs and internists accounted nationally for 57% of SGLT2i and 52% of GLP1RA prescriptions in 2020, more than any other specialty, according to new research.
.jpeg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Study: Only 3% of Adults with Overweight or Obesity in England are Referred to Weight Management Programs by Primary Care Clinician")
